Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas (REGOBONE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02389244
Recruitment Status : Recruiting
First Posted : March 17, 2015
Last Update Posted : April 2, 2021
Sponsor:
Information provided by (Responsible Party):
UNICANCER